Brand-name GLP-1 medications can be expensive when paid out of pocket
These risks include persons with personal or family history with cardiovascular diseases, thyroid tumors, chronic kidney, renal function, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome and hepatic failure, as well as those patients already receiving insulin therapy and certain diabetes medications
We provide guidance on manufacturer savings programs and alternative financing if a prescribed peptide treatment for weight loss isnt covered
Side effects follow the standard timeline with peak symptoms during weeks 6-8
However, decisions about continuing or changing diabetes medications should always be made collaboratively with your healthcare team, weighing the benefits of improved glucose control against any troublesome side effects
This is an important question without a definitive clinical answer yet